In vitro Antioxidant, Cytotoxic, and Anti-Tubercular activities of Cleome gynandrawhole plant extracts
DOI:
https://doi.org/10.47957/ijciar.v6i3.156Keywords:
Cleome gynandra, antioxidant, anticancer, selective cytotoxicity, cell lines, DPPH assay, SRB assay, natural compounds, phytochemicalsAbstract
The current study investigates the antioxidant, anticancer, and anti-TB characteristics of Cleome gynandra, a traditional medicine herb. The research shows that C. gynandra has significant radical scavenging activity, suggesting it may be a natural antioxidant that can reduce oxidative stress and cancer. Several cell lines were cytotoxic by plant extracts. The ethanol extract had the maximum cytotoxicity against MCF-7 cells, while the diethyl ether extract had the highest against HCT-116 cells. The hexane extract cytotoxically affected HepG2, HCT-116, and L6 cells. The aqueous extract of C. gynandra had the lowest cytotoxicity of the cell lines studied. The cytotoxic effects of C. gynandra extracts were highly selective, especially when targeting MCF-7 and HCT-116 cell lines. The study found that the hexane extract had the strongest anti-tuberculosis (TB) effects, with an IC50 of 1.01 µg/ml. The ethanol extract had a substantially lower IC50 value of 7.599 µg/ml, while the ether extract had an IC50 value of 32.7 µg/ml. Finally, the aqueous extract had the highest IC50 value of 793.3 µg/ml. The results suggest that C. gynandra could be used to generate natural anticancer drugs with fewer side effects. The plant's potential anticancer effect's mechanism needs further in vitro and in vivo research.
Downloads
References
Greenwell M., Rahman P.K. Medicinal Plants: Their Use in Anticancer Treatment. Int. J. Pharm. Sci. Res. 2015;6:4103–4112. doi: 10.13040/IJPSR.0975-8232.6(10).4103-12. DOI: https://doi.org/10.13040/IJPSR.0975-8232.6(10).4103-12
Siegel R.L., Miller K.D., Jemal A. Cancer Statistics, 2017. CA Cancer J. Clin. 2017;67:7–30. doi: 10.3322/caac.21387. DOI: https://doi.org/10.3322/caac.21387
Banerjee P., Erehman J., Gohlke B.O., Wilhelm T., Preissner R., Dunkel M. Super Natural II—A database of natural products. Nucleic Acids Res. 2015;43:D935–D939. doi: 10.1093/nar/gku886. C. Melissa, R. Siegel. Ame Cancer Soc: Atlanta, GA, USA; (2018);https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf
Adhikari PP, Paul SB, Choudhury MD, Choudhury S. GC-MS studieson the steam-distillate of the medicinally important plant Cleomegynandra L. Int J Appl Res Stud 2014;3:1-4. DOI: https://doi.org/10.20908/ijars.v3i8.7473
Aparadh VT, Mahamuni RJ, Karadge BA. Taxonomy and physiologicalstudies in spider flower (Cleome species): A critical review. Plant SciFeed 2012;2:25-46.
The Plant List. The Plant List, Version 1; 2010. Available from: http://www.theplantlist.org. [Last cited on Jan 01] [Last accessed on Aug 15].
Ravichandra B, Ram PS, Saritha C, Shankaraiah P. Anti-diabetic andanti-dyslipidemia activities of Cleome gynandra in alloxan induceddiabetic rats. J Pharm Toxicol 2014;9:55-61. DOI: https://doi.org/10.3923/jpt.2014.55.61
Marshall DM, Muhaidat R, Brown NJ, Liu Z, Stanley S, Griffiths H,et al. Cleome, a genus closely related to Arabidopsis, containsspecies spanning a developmental progression from C(3) to C(4)photosynthesis. Plant J 2007;51:886-96. DOI: https://doi.org/10.1111/j.1365-313X.2007.03188.x
Kori ML, Gaur K, Dixit VK. Investigation of immunomodulatorypotential of Cleome gynandra Linn. Asian J Pharm Clin Res2009;2:35-9.
Albarello N, Simões C, Rosas PF, Castro TC, Gianfaldoni MG,CalladoCH, et al. In vitro propagation of Cleome spinosa (Capparaceae)using explants from nursery-grown seedlings and axenic plants. VitroCell Dev Biol Plant 2006;42:601-6. DOI: https://doi.org/10.1079/IVP2006828
Mishra SS, Moharana SK, Dash MR. Review on Cleome gynandra. IntJ Res Pharm Chem 2011;1:681-9.
Chweya JA, Mnzava NA. Cat’s Whiskers, Cleome gynandra L. Vol. 11.Rome, Italy: Bioversity International; 1997.
Anbazhagi T, Kadavul K, Suguna G, Petrus AJ. Studies onpharmacognostical and in vitro antioxidant potential of Cleomegynandra Linn. leaves. Nat Prod Radian 2009;8:151-7.
Paul SB, Choudhury S, Adhikari PP. Isolated chemical componentsfrom spider weed, Cleome gynandra Linn: An overview. Assam Univ JSci Technol 2012;10:166-73.
Misra RN, Dutt S. Chemical examination of cleoaie Pentaphylla Linn.Part Ii. oonstituents of the oil from. The seeds. Proc Natl Inst Sci India1937;3:45.
Gupta RK, Chandra S, Mahadevan B. Chemical examination of seedsof Gynandropsis pentaphylla. Indian J Pharm 1968;30:127.
Saleh M. Phytochemical and botanical study of Gynandropsis sp.Part-I. Gynandropsis glucosinolates. Pharmazie 1976;31:818.
Hasapis X, MacLeod AJ, Moreau M. Glucosinolates of nine cruciferaeand two Capparaceae species. Phytochemistry 1981;20:2355-8. DOI: https://doi.org/10.1016/S0031-9422(00)82665-5
Ali AA, Sayed HM, Mesbah MK. Pharmacognosical study ofGynandropsis pentaphylla growing in Egypt, Pt. III. Bull Pharm SciAssiut Univ 1987;10:74. DOI: https://doi.org/10.21608/bfsa.1987.74030
Jain AC, Gupta SM. Minor phenolic components of the seeds ofGynandropsis gynandra. J Nat Prod 1985;48:332-3. DOI: https://doi.org/10.1021/np50038a029
Rastogi RP, Mehrotra BN. Cleome gynandra, Compendium of IndianMedicinal Plants. Vol. II, III, IV. New Delhi: CSIR; 1993. p. 112, 182,193, 198.
Ragunathan V, Jaswant V, Sulochana N. Rutin from flowers of Cleomegyanandra Linn. J Ind Chem Soc 1997;74:821.
Das PC, Patra A, Mandal S, Mallick B, Das A, Chatterjee A. Cleogynol,a novel dammarane triterpenoid from Cleome gynandra. J Nat Prod1999;62:616-8. DOI: https://doi.org/10.1021/np9803528
Lwande W, Ndakala A, Hassanali A, Moreka L, Nyandat E, Ndungu M,et al. Gynandropsis gynandra essential oil and its constituents astick (Rhipicephalus appendiculatus) repellents. Phytochemistry1999;50:401-5. DOI: https://doi.org/10.1016/S0031-9422(98)00507-X
Published
How to Cite
Issue
Section
Citations
This work is licensed under a Creative Commons Attribution 4.0 International License.
